Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 20  •  04:00PM ET
25.89
Dollar change
+1.03
Percentage change
4.14
%
Index
RUT
P/E
2139.67
EPS (ttm)
0.01
Insider Own
17.95%
Shs Outstand
106.32M
Perf Week
21.66%
Market Cap
3.17B
Forward P/E
40.10
EPS next Y
0.65
Insider Trans
-4.25%
Shs Float
100.47M
Perf Month
6.24%
Enterprise Value
3.12B
PEG
1.02
EPS next Q
0.10
Inst Own
89.21%
Perf Quarter
-8.06%
Income
1.64M
P/S
3.64
EPS this Y
33.99%
Inst Trans
12.14%
Perf Half Y
20.25%
Sales
871.90M
P/B
8.62
EPS next Y
34.03%
ROA
0.23%
Perf YTD
18.82%
Book/sh
3.00
P/C
11.07
EPS next 5Y
39.23%
ROE
0.46%
52W High
31.00 -16.48%
Perf Year
81.56%
Cash/sh
2.34
P/FCF
72.48
EPS past 3/5Y
- -
ROIC
0.29%
52W Low
13.63 89.95%
Perf 3Y
144.71%
Dividend Est.
-
EV/EBITDA
63.64
Sales past 3/5Y
13.39% 17.23%
Gross Margin
51.92%
Volatility
6.94% 6.39%
Perf 5Y
-
Dividend TTM
-
EV/Sales
3.57
EPS Y/Y TTM
108.04%
Oper. Margin
-0.55%
ATR (14)
1.51
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
2.02
Sales Y/Y TTM
13.04%
Profit Margin
0.19%
RSI (14)
63.95
Dividend Gr. 3/5Y
- -
Current Ratio
2.32
EPS Q/Q
14.66%
SMA20
16.79%
Beta
2.08
Payout
0.00%
Debt/Eq
0.63
Sales Q/Q
11.19%
SMA50
11.20%
Rel Volume
1.20
Prev Close
24.86
Employees
4036
LT Debt/Eq
0.55
SMA200
8.61%
Avg Volume
2.90M
Price
25.89
IPO
Sep 29, 2021
Option/Short
Yes / Yes
Trades
Volume
3,492,378
Change
4.14%
Date Action Analyst Rating Change Price Target Change
Dec-10-25Upgrade Citizens JMP Mkt Perform → Mkt Outperform $30
Nov-07-25Reiterated Telsey Advisory Group Outperform $28 → $24
Aug-01-25Reiterated Telsey Advisory Group Outperform $22 → $28
Jul-10-25Downgrade Citizens JMP Mkt Outperform → Mkt Perform
Apr-30-25Upgrade Citigroup Sell → Neutral $17
Apr-17-25Upgrade Loop Capital Hold → Buy $27
Feb-28-25Reiterated Telsey Advisory Group Outperform $28 → $30
Feb-25-25Initiated ROTH MKM Neutral $26
Feb-05-25Downgrade Citigroup Neutral → Sell $19 → $23
Jan-17-25Downgrade Evercore ISI Outperform → In-line $23
Apr-20-26 05:00AM
Apr-16-26 04:05PM
Mar-10-26 12:03AM
Mar-01-26 02:05AM
Feb-27-26 05:38AM
08:10PM Loading…
Feb-26-26 08:10PM
04:11PM
02:15PM
09:55AM
07:32AM
06:54AM
06:45AM
Feb-25-26 07:26AM
Feb-24-26 10:13PM
Feb-17-26 01:02PM
03:50PM Loading…
Feb-13-26 03:50PM
Feb-12-26 07:00AM
Feb-10-26 08:49AM
Feb-09-26 04:10PM
Feb-03-26 08:55PM
05:35PM
Jan-30-26 05:52AM
Jan-28-26 03:01PM
09:02AM
09:02AM
Jan-25-26 10:32PM
Jan-23-26 07:36AM
Jan-14-26 07:09AM
Jan-13-26 11:05PM
Jan-12-26 01:30PM
07:31PM Loading…
Jan-06-26 07:31PM
12:29PM
12:29PM
Jan-05-26 12:15PM
Jan-02-26 01:46PM
Dec-23-25 11:48AM
Dec-17-25 01:01PM
Dec-15-25 10:45AM
Dec-14-25 02:41PM
Dec-13-25 07:00AM
Dec-11-25 10:19AM
Dec-10-25 02:09PM
10:35AM
Dec-09-25 04:54PM
02:22PM
02:16PM
11:14AM
11:00AM
Dec-08-25 07:26PM
Nov-26-25 07:00AM
Nov-18-25 01:21PM
Nov-13-25 12:32AM
Nov-12-25 10:38AM
Nov-07-25 09:41AM
09:30AM
Nov-06-25 02:09PM
01:56PM
12:16PM
07:55AM
07:15AM
06:45AM
Nov-05-25 07:31AM
Nov-04-25 10:09PM
Oct-31-25 03:21PM
Oct-16-25 07:00AM
Oct-08-25 12:02AM
Oct-07-25 11:36PM
Oct-05-25 03:53PM
Sep-23-25 05:35AM
Sep-22-25 10:22AM
Sep-16-25 10:43AM
Sep-11-25 09:00AM
Sep-05-25 04:23PM
Aug-28-25 04:05PM
Aug-27-25 10:27PM
09:00AM
Aug-14-25 04:45PM
01:33AM
Aug-13-25 12:05PM
11:24AM
Aug-12-25 09:58AM
03:22AM
Aug-11-25 04:45AM
Aug-10-25 05:30AM
Aug-07-25 02:32PM
09:30AM
08:05AM
07:27AM
06:45AM
Aug-06-25 07:10AM
Aug-05-25 11:02PM
Aug-01-25 01:56PM
07:15AM
Jul-31-25 05:25PM
10:00AM
Jul-23-25 10:00AM
Jul-17-25 06:05PM
04:05PM
Jul-09-25 10:31AM
08:25AM
Warby Parker, Inc. is an online retailer of eyewear for men and women, which engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on May 7, 2010 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blumenthal Neil HarrisCo-Chief Executive OfficerApr 17 '26Sale24.5675,2131,847,59250,165Apr 20 08:45 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerApr 20 '26Sale25.0922,442563,07050,165Apr 20 08:45 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerApr 16 '26Sale24.082,34556,46850,165Apr 20 08:45 PM
NEIL BLUMENTHALDirectorApr 17 '26Proposed Sale23.1750,0001,158,500Apr 17 04:33 PM
NEIL BLUMENTHALDirectorApr 16 '26Proposed Sale23.6650,0001,183,000Apr 16 04:12 PM
Raider Jeffrey JacobDirectorMar 11 '26Sale25.4325,000635,750448,697Mar 13 06:07 PM
JEFFREY RAIDERDirectorMar 11 '26Proposed Sale25.4325,000635,780Mar 11 04:07 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerMar 05 '26Option Exercise0.0013,475057,618Mar 06 05:13 PM
Gilboa David AbrahamCo-Chief Executive OfficerMar 05 '26Option Exercise0.0013,475057,746Mar 06 05:12 PM
SINGER BRADLEY EDirectorMar 04 '26Sale27.5315,793434,78116,026Mar 06 05:10 PM
BRADLEY SINGERDirectorMar 04 '26Proposed Sale27.5315,793434,824Mar 04 05:35 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJan 13 '26Sale29.9966019,79337,119Jan 15 06:36 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 13 '26Sale29.4680,0942,359,56937,247Jan 15 06:35 PM
DAVID GILBOADirectorJan 13 '26Proposed Sale26.5880,0942,128,899Jan 13 04:22 PM
NEIL BLUMENTHALDirectorJan 13 '26Proposed Sale26.5866017,543Jan 13 04:21 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 07 '26Sale27.0975,0002,031,75037,247Jan 09 08:48 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 09 '26Sale29.0919,906579,06637,247Jan 09 08:48 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJan 07 '26Sale27.0850,0001,354,00037,119Jan 09 08:47 PM
DAVID GILBOADirectorJan 09 '26Proposed Sale28.2819,906562,942Jan 09 04:31 PM
NEIL BLUMENTHALDirectorJan 07 '26Proposed Sale25.9450,0001,297,000Jan 07 04:25 PM
DAVID GILBOADirectorJan 07 '26Proposed Sale25.9475,0001,945,500Jan 07 04:24 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJan 06 '26Sale25.09150,0003,763,50037,119Jan 06 08:55 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 06 '26Sale24.2950,0001,214,50037,247Jan 06 08:53 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 02 '26Sale22.4625,000561,50037,247Jan 06 08:53 PM
NEIL BLUMENTHALDirectorJan 06 '26Proposed Sale23.25150,0003,487,500Jan 06 04:31 PM
DAVID GILBOADirectorJan 06 '26Proposed Sale23.2550,0001,162,500Jan 06 04:28 PM
DAVID GILBOADirectorJan 02 '26Proposed Sale21.7925,000544,750Jan 02 04:33 PM
Cutler Joel EDirectorDec 16 '25Sale26.0119,932518,47720,000Dec 18 04:35 PM
Joel CutlerDirectorDec 16 '25Proposed Sale26.6532,249859,436Dec 16 06:13 PM
Moon Youngme EDirectorDec 11 '25Sale29.0738,8321,128,84627,057Dec 15 05:30 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerDec 11 '25Sale30.29100,0003,029,00037,119Dec 15 05:29 PM
Raider Jeffrey JacobDirectorDec 12 '25Sale27.4225,000685,500483,485Dec 15 05:28 PM
Gilboa David AbrahamCo-Chief Executive OfficerDec 11 '25Sale30.20200,0006,040,00037,247Dec 15 05:27 PM
Warby Parker Impact Foundation10% OwnerDec 15 '25Proposed Sale27.40178,5724,892,873Dec 15 03:16 PM
JEFFREY RAIDEROfficerDec 12 '25Proposed Sale27.4225,000685,618Dec 12 04:28 PM
David GilboaDirectorDec 11 '25Proposed Sale29.57200,0005,914,000Dec 11 04:25 PM
NEIL BLUMENTHALDirectorDec 11 '25Proposed Sale29.57100,0002,957,000Dec 11 04:24 PM
YOUNGME MOONDirectorDec 11 '25Proposed Sale29.0738,8321,128,846Dec 11 04:06 PM
Gilboa David AbrahamCo-Chief Executive OfficerDec 02 '25Option Exercise0.009,816042,677Dec 04 05:03 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerDec 02 '25Option Exercise0.009,816042,549Dec 04 05:02 PM
Gilboa David AbrahamCo-Chief Executive OfficerOct 01 '25Sale27.30125,0003,412,50032,861Oct 03 05:50 PM
Gilboa David AbrahamCo-Chief Executive OfficerSep 18 '25Sale27.5858,3601,609,56932,861Sep 19 05:42 PM
Gilboa David AbrahamCo-Chief Executive OfficerSep 17 '25Sale27.5260016,51232,861Sep 19 05:42 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerSep 18 '25Sale27.528,416231,60832,733Sep 19 05:40 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerSep 17 '25Sale27.5250013,76032,733Sep 19 05:40 PM
David GilboaDirectorSep 18 '25Proposed Sale26.75175,0004,681,250Sep 18 04:26 PM
Gilboa David AbrahamCo-Chief Executive OfficerSep 11 '25Sale27.5341,0401,129,83132,861Sep 15 05:17 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerSep 11 '25Sale27.5341,0841,131,04332,733Sep 15 05:16 PM
NEIL BLUMENTHALDirectorSep 11 '25Proposed Sale27.0150,0001,350,500Sep 11 04:31 PM
David GilboaDirectorSep 11 '25Proposed Sale27.0150,0001,350,500Sep 11 04:31 PM
Cutler Joel EDirectorSep 08 '25Sale26.7535,000936,35219,932Sep 10 08:53 PM
Joel CutlerDirectorSep 08 '25Proposed Sale26.7535,000936,250Sep 08 05:55 PM
Gilboa David AbrahamCo-Chief Executive OfficerSep 03 '25Option Exercise0.009,815038,290Sep 05 05:15 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerSep 03 '25Option Exercise0.009,815038,162Sep 05 05:13 PM
Miller Steven CliveChief Financial OfficerSep 03 '25Option Exercise0.0028,4750248,875Sep 05 05:12 PM
Briggs TeresaDirectorAug 11 '25Sale23.566,000141,36044,879Aug 13 08:22 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerAug 13 '25Sale25.1150,0001,255,50028,347Aug 13 08:19 PM
NEIL BLUMENTHALDirectorAug 13 '25Proposed Sale24.4150,0001,220,500Aug 13 04:22 PM
Teresa BriggsDirectorAug 11 '25Proposed Sale23.566,000141,338Aug 11 04:05 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJul 21 '25Sale24.2149,6001,200,81628,347Jul 22 06:00 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJul 18 '25Sale24.014009,60428,347Jul 22 06:00 PM
Gilboa David AbrahamCo-Chief Executive OfficerJul 21 '25Sale24.2774,5001,808,11528,475Jul 22 05:58 PM
Gilboa David AbrahamCo-Chief Executive OfficerJul 18 '25Sale24.0150012,00528,475Jul 22 05:58 PM
David GilboaDirectorJul 18 '25Proposed Sale23.4575,0001,758,750Jul 18 04:47 PM
NEIL BLUMENTHALDirectorJul 18 '25Proposed Sale23.4550,0001,172,500Jul 18 04:47 PM
Gilboa David AbrahamCo-Chief Executive OfficerJul 01 '25Sale22.0450,0001,102,00028,475Jul 03 05:00 PM
David GilboaDirectorJul 01 '25Proposed Sale21.9350,0001,096,500Jul 01 04:32 PM
Gilboa David AbrahamCo-Chief Executive OfficerJun 03 '25Option Exercise0.009,816033,905Jun 05 08:23 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJun 03 '25Option Exercise0.009,816033,777Jun 05 08:22 PM
Miller Steven CliveChief Financial OfficerJun 03 '25Option Exercise0.0030,1750237,092Jun 05 08:21 PM
Moon Youngme EDirectorMay 22 '25Sale19.9033,073658,15353,869May 27 05:13 PM
Moon Youngme EDirectorMay 22 '25Proposed Sale19.9033,073658,153May 22 04:29 PM
Last Close
Apr 20  •  04:00PM ET
25.53
Dollar change
+0.45
Percentage change
1.79
%
STAA Staar Surgical Co daily Stock Chart
Index
RUT
P/E
-
EPS (ttm)
-1.63
Insider Own
0.69%
Shs Outstand
49.40M
Perf Week
-4.88%
Market Cap
1.26B
Forward P/E
40.51
EPS next Y
0.63
Insider Trans
-
Shs Float
49.17M
Perf Month
46.14%
Enterprise Value
1.11B
PEG
-
EPS next Q
0.03
Inst Own
109.54%
Perf Quarter
21.75%
Income
-80.45M
P/S
5.28
EPS this Y
138.88%
Inst Trans
-1.93%
Perf Half Y
5.23%
Sales
239.44M
P/B
3.66
EPS next Y
62.09%
ROA
-16.57%
Perf YTD
10.57%
Book/sh
6.97
P/C
6.74
EPS next 5Y
-
ROE
-21.70%
52W High
30.81 -17.14%
Perf Year
51.15%
Cash/sh
3.79
P/FCF
-
EPS past 3/5Y
- -
ROIC
-21.36%
52W Low
15.59 63.81%
Perf 3Y
-63.77%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-5.57% 7.93%
Gross Margin
74.01%
Volatility
5.13% 5.43%
Perf 5Y
-78.51%
Dividend TTM
-
EV/Sales
4.66
EPS Y/Y TTM
-296.85%
Oper. Margin
-20.26%
ATR (14)
1.28
Perf 10Y
229.84%
Dividend Ex-Date
-
Quick Ratio
3.74
Sales Y/Y TTM
-23.72%
Profit Margin
-33.60%
RSI (14)
68.46
Dividend Gr. 3/5Y
- -
Current Ratio
4.55
EPS Q/Q
47.04%
SMA20
17.22%
Beta
1.13
Payout
-
Debt/Eq
0.11
Sales Q/Q
18.08%
SMA50
30.31%
Rel Volume
0.39
Prev Close
25.08
Employees
957
LT Debt/Eq
0.09
SMA200
10.74%
Avg Volume
1.40M
Price
25.53
IPO
Jul 07, 1983
Option/Short
Yes / Yes
Trades
Volume
545,194
Change
1.79%
Date Action Analyst Rating Change Price Target Change
Apr-09-26Upgrade Canaccord Genuity Hold → Buy $27
Feb-03-26Initiated Wedbush Neutral $26
Jan-16-26Resumed Morgan Stanley Underweight $13
Apr-21-25Initiated Wells Fargo Equal Weight $17
Feb-12-25Downgrade William Blair Outperform → Mkt Perform
Feb-12-25Downgrade Mizuho Outperform → Neutral $45 → $17
Feb-12-25Downgrade Jefferies Buy → Hold
Feb-12-25Downgrade BTIG Research Buy → Neutral
Jul-15-24Downgrade Morgan Stanley Equal-Weight → Underweight $50 → $37
Jun-11-24Upgrade BTIG Research Neutral → Buy $46
Apr-09-26 01:32PM
06:26AM
Apr-08-26 04:01PM
Mar-17-26 06:57AM
Mar-04-26 08:30AM
12:02AM Loading…
12:02AM
Mar-03-26 07:02PM
05:15PM
04:34PM
04:21PM
04:02PM
04:01PM
Mar-02-26 09:36AM
Feb-26-26 05:30PM
Feb-25-26 04:01PM
12:31PM Loading…
Feb-24-26 12:31PM
08:31AM
Feb-23-26 04:01PM
08:46AM
08:45AM
Feb-19-26 12:08PM
Feb-18-26 05:18AM
Feb-17-26 04:01PM
Feb-09-26 11:37PM
Feb-05-26 10:00AM
07:55AM
Feb-04-26 01:27PM
Feb-03-26 10:00AM
09:34AM
05:23AM
12:55PM Loading…
Feb-02-26 12:55PM
07:00AM
Jan-30-26 01:00PM
Jan-25-26 08:18PM
Jan-23-26 04:35PM
Jan-16-26 08:39PM
09:32AM
08:02AM
05:00AM
Jan-15-26 11:04PM
01:06PM
08:30AM
Jan-13-26 08:45AM
Jan-07-26 07:38AM
Jan-06-26 08:00PM
12:32PM
12:14PM
09:52AM
08:47AM
06:13AM
Dec-19-25 03:51PM
12:59PM
11:45AM
Dec-17-25 06:47PM
04:53PM
01:17PM
10:55AM
Dec-16-25 03:58PM
01:32PM
09:12AM
07:00AM
Dec-15-25 06:35PM
Dec-12-25 05:29PM
08:40AM
Dec-11-25 08:06PM
11:41AM
09:47AM
07:00AM
Dec-10-25 01:34PM
07:05AM
Dec-09-25 02:25PM
02:16PM
12:39PM
12:00PM
08:30AM
Dec-08-25 04:11PM
01:28PM
08:16AM
08:00AM
Dec-04-25 10:35PM
Dec-03-25 12:02PM
Dec-02-25 04:14PM
Nov-26-25 03:34PM
Nov-18-25 04:15PM
Nov-12-25 02:35PM
Nov-10-25 06:38PM
01:00PM
08:00AM
Nov-07-25 04:22PM
10:10AM
Nov-06-25 06:21AM
Nov-05-25 04:27PM
04:01PM
Nov-04-25 11:32PM
03:13PM
11:52AM
01:00AM
Oct-31-25 12:00PM
11:14AM
Oct-27-25 04:43PM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Foust WarrenInterim Co-CEO and Pres. & COOMar 14 '26Option Exercise0.0029,325063,588Mar 16 05:00 PM
Foust WarrenInterim Co-CEO and Pres. & COOMar 12 '26Option Exercise0.008,175034,263Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 14 '26Option Exercise0.0017,595036,001Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 12 '26Option Exercise0.006,178020,622Mar 16 05:00 PM
BROADWOOD PARTNERS, L.P.DirectorMar 13 '26Buy18.61316,0175,882,65616,123,842Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 12 '26Buy18.12299,4325,424,33015,807,825Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 11 '26Buy17.5254,764959,55815,508,393Mar 13 07:59 PM
Jiang WeiDirectorJan 12 '26Option Exercise0.0020,967066,444Jan 14 05:48 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 09 '26Buy22.0527,485606,13815,453,629Jan 13 09:30 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 06 '26Buy21.62336,9467,284,28115,356,437Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 07 '26Buy22.0066,4671,462,30115,422,904Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 08 '26Buy21.943,24071,08215,426,144Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 21 '25Buy27.86797,48622,218,83715,019,491Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 20 '25Buy27.14393,38210,675,32514,222,005Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 19 '25Buy26.42309,1328,166,15513,828,623Nov 21 09:55 PM
Jiang WeiDirectorNov 12 '25Option Exercise0.0020,967045,477Nov 14 06:00 PM
Jiang WeiDirectorAug 12 '25Option Exercise0.0020,967024,510Aug 13 06:39 PM
WEISNER AIMEE SFormer DirectorAug 05 '25Proposed Sale26.871,75047,025Aug 05 06:38 PM
WEISNER AIMEE SFormer DirectorAug 05 '25Proposed Sale26.8713,491362,523Aug 05 06:33 PM
Last Close
Apr 20  •  04:00PM ET
25.49
Dollar change
-0.19
Percentage change
-0.74
%
EYE National Vision Holdings Inc daily Stock Chart
Index
RUT
P/E
68.89
EPS (ttm)
0.37
Insider Own
2.19%
Shs Outstand
79.42M
Perf Week
2.37%
Market Cap
2.02B
Forward P/E
20.34
EPS next Y
1.25
Insider Trans
-2.61%
Shs Float
77.69M
Perf Month
-10.37%
Enterprise Value
2.68B
PEG
0.82
EPS next Q
0.43
Inst Own
117.49%
Perf Quarter
-9.00%
Income
29.60M
P/S
1.02
EPS this Y
23.75%
Inst Trans
3.56%
Perf Half Y
-5.77%
Sales
1.99B
P/B
2.33
EPS next Y
26.58%
ROA
1.38%
Perf YTD
-1.28%
Book/sh
10.95
P/C
52.31
EPS next 5Y
24.76%
ROE
3.51%
52W High
30.02 -15.09%
Perf Year
118.42%
Cash/sh
0.49
P/FCF
27.57
EPS past 3/5Y
-11.20% -3.46%
ROIC
2.03%
52W Low
10.75 137.12%
Perf 3Y
26.44%
Dividend Est.
-
EV/EBITDA
17.78
Sales past 3/5Y
-0.30% 3.03%
Gross Margin
54.18%
Volatility
4.24% 5.79%
Perf 5Y
-46.14%
Dividend TTM
-
EV/Sales
1.35
EPS Y/Y TTM
203.65%
Oper. Margin
3.00%
ATR (14)
1.47
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.33
Sales Y/Y TTM
5.55%
Profit Margin
1.49%
RSI (14)
48.05
Dividend Gr. 3/5Y
- -
Current Ratio
0.55
EPS Q/Q
111.18%
SMA20
-0.39%
Beta
1.28
Payout
0.00%
Debt/Eq
0.80
Sales Q/Q
15.12%
SMA50
-4.47%
Rel Volume
0.85
Prev Close
25.68
Employees
13138
LT Debt/Eq
0.68
SMA200
-2.49%
Avg Volume
1.32M
Price
25.49
IPO
Oct 26, 2017
Option/Short
Yes / Yes
Trades
Volume
1,123,824
Change
-0.74%
Date Action Analyst Rating Change Price Target Change
Dec-10-25Initiated Guggenheim Buy $32
Jul-30-25Initiated Roth Capital Buy $36
Jul-08-25Upgrade Barclays Equal Weight → Overweight $30
May-09-25Upgrade Citigroup Neutral → Buy $21
May-07-25Upgrade BofA Securities Underperform → Buy
Oct-17-23Downgrade Goldman Buy → Neutral $25 → $16
Jul-27-23Downgrade Wells Fargo Overweight → Equal Weight $30 → $21
Jul-27-23Downgrade Citigroup Buy → Neutral $28 → $22
May-02-23Downgrade Barclays Overweight → Equal Weight
Mar-31-23Upgrade Loop Capital Hold → Buy $23
Mar-24-26 09:40AM
Mar-23-26 07:00AM
Mar-17-26 07:00AM
Mar-12-26 04:00PM
07:00AM
09:05AM Loading…
Mar-10-26 09:05AM
08:00AM
Mar-05-26 09:40AM
07:43AM
Mar-04-26 04:02PM
03:17PM
12:32PM
10:36AM
09:30AM
07:10AM
06:27AM Loading…
06:27AM
06:17AM
06:12AM
06:00AM
Mar-02-26 10:01PM
Feb-26-26 09:55AM
Feb-25-26 09:40AM
Feb-24-26 08:00AM
Feb-23-26 11:41PM
11:40AM
Feb-20-26 09:50AM
Feb-19-26 10:37AM
Feb-18-26 07:00AM
Feb-16-26 11:39PM
Feb-10-26 11:43AM
11:11AM Loading…
11:11AM
Feb-06-26 09:31AM
Feb-05-26 09:25AM
Feb-04-26 12:15PM
09:34AM
Feb-01-26 11:43PM
Jan-30-26 08:05AM
Jan-29-26 08:48AM
Jan-28-26 09:55AM
09:50AM
Jan-27-26 06:25PM
Jan-26-26 12:10PM
Jan-25-26 11:34PM
Jan-22-26 09:49AM
09:40AM
Jan-16-26 07:50AM
Jan-15-26 03:46PM
02:36PM
Jan-13-26 07:00AM
Jan-11-26 11:31PM
Jan-07-26 06:07PM
11:46AM
Jan-06-26 04:05PM
Dec-30-25 11:31PM
Dec-19-25 09:09AM
Dec-18-25 11:32PM
11:30AM
Dec-16-25 10:36PM
Dec-10-25 11:03PM
Dec-05-25 11:30AM
Nov-26-25 08:00AM
Nov-18-25 02:15PM
Nov-17-25 06:45AM
Nov-12-25 12:32AM
Nov-06-25 06:00PM
09:30AM
12:31AM
Nov-05-25 12:25PM
07:20AM
06:25AM
06:16AM
06:00AM
Nov-03-25 10:23PM
Oct-31-25 07:10AM
Oct-28-25 12:01AM
Oct-22-25 08:00AM
Oct-09-25 11:31PM
Oct-07-25 09:01AM
Oct-01-25 12:39AM
Sep-30-25 12:32AM
Sep-25-25 09:31AM
Sep-19-25 05:09AM
Sep-02-25 04:40PM
Aug-20-25 08:00AM
Aug-19-25 09:00AM
Aug-13-25 01:35AM
Aug-12-25 08:22AM
03:06AM
Aug-08-25 03:43PM
Aug-07-25 01:00PM
Aug-06-25 07:10AM
06:19AM
06:09AM
06:00AM
Aug-05-25 09:44AM
08:00AM
Aug-04-25 11:02PM
Aug-01-25 11:13AM
Jul-30-25 09:40AM
08:21AM
National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate and Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate and Other segment relates to the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilkes AlexanderChief Executive OfficerMar 11 '26Sale26.5435,000928,90016,431Mar 12 04:15 PM
Wilkes AlexanderOfficerMar 11 '26Proposed Sale27.3035,000955,500Mar 11 10:59 AM
FAHS L READEExecutive ChairmanMar 06 '26Sale29.587,601224,838694,880Mar 09 04:19 PM
FAHS L READEExecutive ChairmanMar 06 '26Sale29.574,071120,379359,359Mar 09 04:19 PM
FAHS L READEMember of immediate family of Mar 06 '26Proposed Sale29.574,071120,391Mar 06 04:35 PM
FAHS L READEOfficerMar 06 '26Proposed Sale29.587,601224,862Mar 06 04:32 PM
Patel Priti VHead of Emerging BrandsMar 03 '26Option Exercise0.0011,951029,720Mar 04 04:24 PM
VanDette JosephChief Brand & Mktg OfficerMar 03 '26Option Exercise0.0025,394047,780Mar 04 04:24 PM
Clark BillSVP, Chief People OfficerMar 03 '26Option Exercise0.0025,394071,926Mar 04 04:23 PM
Brandman JaredChief Legal & Strategy OfficerMar 03 '26Option Exercise0.0025,394076,748Mar 04 04:23 PM
FAHS L READEExecutive ChairmanMar 03 '26Option Exercise0.00179,2480751,914Mar 04 04:22 PM
FAHS L READEExecutive ChairmanSep 16 '25Sale23.9310,598253,610532,195Sep 17 04:11 PM
FAHS L READEExecutive ChairmanSep 15 '25Sale23.812,00247,668542,793Sep 17 04:11 PM
FAHS L READEOfficerSep 16 '25Proposed Sale23.9310,598253,629Sep 16 04:16 PM
FAHS L READEOfficerSep 15 '25Proposed Sale23.812,00247,670Sep 15 04:12 PM
FAHS L READEExecutive ChairmanAug 28 '25Sale24.33137,4003,343,174544,795Aug 29 04:16 PM
FAHS L READEOfficerAug 28 '25Proposed Sale24.33137,4003,343,335Aug 28 04:16 PM
Molony MeganSVP, CHIEF MERCH. & MC OFFICERMay 15 '25Option Exercise15.0712,206183,94416,181May 16 04:30 PM
Molony MeganSVP, CHIEF MERCH. & MC OFFICERMay 14 '25Sale18.903,90073,7103,975May 16 04:30 PM
Moore Patrick R.Former OfficerMay 16 '25Proposed Sale19.1315,983305,751May 16 02:29 PM
Molony MeganOfficerMay 15 '25Proposed Sale18.6010,581196,807May 15 01:11 PM
Acharya RaviSVP, Chief Technology OfficerMay 13 '25Sale18.7512,000225,06011,700May 14 04:37 PM
Molony MeganOfficerMay 14 '25Proposed Sale18.903,90073,710May 14 11:53 AM
Acharya RaviOfficerMay 13 '25Proposed Sale18.7512,000225,060May 13 03:34 PM
Rasmussen MelissaFormer OfficerMay 07 '25Proposed Sale15.5128,869447,698May 07 05:03 PM
Last Close
Apr 20  •  04:00PM ET
16.76
Dollar change
-0.06
Percentage change
-0.36
%
BLCO Bausch + Lomb Corp daily Stock Chart
Index
-
P/E
-
EPS (ttm)
-1.02
Insider Own
89.29%
Shs Outstand
354.21M
Perf Week
0.84%
Market Cap
5.94B
Forward P/E
15.83
EPS next Y
1.06
Insider Trans
0.02%
Shs Float
37.94M
Perf Month
3.65%
Enterprise Value
10.86B
PEG
0.40
EPS next Q
0.05
Inst Own
10.56%
Perf Quarter
-2.33%
Income
-360.00M
P/S
1.16
EPS this Y
51.57%
Inst Trans
-0.83%
Perf Half Y
12.79%
Sales
5.10B
P/B
0.92
EPS next Y
36.96%
ROA
-2.62%
Perf YTD
-1.87%
Book/sh
18.20
P/C
14.96
EPS next 5Y
39.78%
ROE
-5.57%
52W High
18.92 -11.39%
Perf Year
38.97%
Cash/sh
1.12
P/FCF
-
EPS past 3/5Y
- -
ROIC
-3.10%
52W Low
10.45 60.38%
Perf 3Y
-2.05%
Dividend Est.
-
EV/EBITDA
17.83
Sales past 3/5Y
10.62% 8.38%
Gross Margin
54.75%
Volatility
1.78% 2.78%
Perf 5Y
-
Dividend TTM
-
EV/Sales
2.13
EPS Y/Y TTM
-12.96%
Oper. Margin
3.69%
ATR (14)
0.48
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
1.04
Sales Y/Y TTM
6.47%
Profit Margin
-7.06%
RSI (14)
53.13
Dividend Gr. 3/5Y
- -
Current Ratio
1.55
EPS Q/Q
-1825.88%
SMA20
3.04%
Beta
0.65
Payout
-
Debt/Eq
0.81
Sales Q/Q
9.77%
SMA50
-0.80%
Rel Volume
0.54
Prev Close
16.82
Employees
13000
LT Debt/Eq
0.80
SMA200
5.99%
Avg Volume
409.17K
Price
16.76
IPO
May 06, 2022
Option/Short
Yes / Yes
Trades
Volume
219,882
Change
-0.36%
Date Action Analyst Rating Change Price Target Change
Jan-05-26Downgrade Evercore ISI Outperform → In-line $18
Dec-11-25Upgrade Citigroup Neutral → Buy $20
Dec-02-25Upgrade Morgan Stanley Equal-Weight → Overweight $21
Oct-01-25Initiated Goldman Neutral $16
May-02-25Reiterated H.C. Wainwright Buy $20 → $15
Mar-28-25Downgrade Wells Fargo Overweight → Equal Weight $24 → $15
Dec-11-24Downgrade Citigroup Buy → Neutral $24 → $22
Dec-02-24Downgrade Morgan Stanley Overweight → Equal-Weight $19
Oct-15-24Upgrade Evercore ISI In-line → Outperform $19 → $25
Jul-10-24Initiated Raymond James Outperform $19
Apr-16-26 07:00AM
Apr-08-26 07:00AM
Apr-07-26 07:00AM
Apr-06-26 07:00AM
Mar-30-26 07:15AM
07:00AM Loading…
Mar-23-26 07:00AM
Mar-11-26 06:00AM
Mar-09-26 07:15AM
Feb-27-26 12:57PM
05:14AM
Feb-25-26 12:36AM
Feb-24-26 07:00AM
Feb-19-26 12:00PM
12:31AM
Feb-18-26 10:11PM
04:31PM Loading…
04:31PM
02:58PM
02:23PM
02:00PM
01:25PM
01:25PM
09:36AM
09:30AM
08:10AM
07:37AM
07:19AM
06:58AM
Feb-16-26 10:07PM
09:15AM
Feb-12-26 08:50AM
09:30AM Loading…
Feb-11-26 09:30AM
Feb-09-26 11:02PM
11:40AM
Jan-29-26 11:34PM
Jan-23-26 11:40AM
Jan-20-26 07:15AM
Jan-05-26 07:00AM
Jan-02-26 04:30PM
Dec-23-25 07:30AM
Dec-17-25 04:30PM
Dec-12-25 04:48PM
Dec-11-25 11:41AM
Dec-04-25 10:09PM
Dec-02-25 11:10AM
Nov-18-25 04:30PM
Nov-13-25 02:57PM
08:55AM
08:41AM
Nov-10-25 06:59AM
04:28AM
Nov-05-25 12:35AM
Nov-03-25 04:30PM
Oct-30-25 01:34AM
Oct-29-25 03:47PM
09:30AM
08:05AM
07:23AM
07:06AM
06:58AM
Oct-28-25 09:26AM
Oct-27-25 11:12PM
Oct-20-25 06:44PM
11:36AM
09:34AM
07:41AM
07:25AM
Oct-19-25 08:00PM
Oct-17-25 12:24PM
Oct-10-25 06:44PM
Oct-02-25 11:40AM
Oct-01-25 11:01AM
Sep-25-25 01:06PM
Sep-11-25 07:00AM
Sep-09-25 07:00AM
Sep-08-25 06:56PM
04:30PM
07:00AM
Sep-05-25 12:41AM
Aug-22-25 02:25PM
Aug-20-25 11:31PM
Aug-18-25 05:48PM
05:01PM
Aug-14-25 07:15AM
Aug-12-25 11:55PM
11:48PM
Aug-07-25 12:38AM
Jul-30-25 03:05PM
12:16PM
09:30AM
08:10AM
07:34AM
07:04AM
06:57AM
05:38AM
Jul-29-25 09:27AM
07:00AM
Jul-28-25 11:09PM
Jul-24-25 05:04AM
Jul-23-25 10:00AM
Jul-22-25 08:45AM
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bailey A Robert DEVP & Chief Legal OfficerMar 06 '26Buy17.1514,600250,332231,890Mar 10 05:23 PM
Eldessouky SamEVP and CFOMar 06 '26Buy17.134,00068,520403,130Mar 10 04:34 PM
SAUNDERS BRENT LCEO and Chairman of the BoardMar 06 '26Buy17.1414,700251,958966,575Mar 10 04:32 PM
Ross Thomas W. Sr.DirectorMar 03 '26Buy17.684,50079,55664,891Mar 04 04:18 PM
Alfonso EduardoDirectorMar 02 '26Buy17.904,30076,9709,555Mar 03 04:26 PM
VON ESCHENBACH ANDREW C.DirectorFeb 27 '26Buy18.304,36479,88366,450Mar 03 04:24 PM
COLLIS STEVEN HDirectorFeb 23 '26Buy17.8115,000267,15020,255Feb 24 04:23 PM
ROBERTSON RUSSEL CDirectorFeb 20 '26Buy17.904,40078,76072,407Feb 24 04:16 PM
Ling KarenDirectorFeb 19 '26Buy17.744,00070,96841,676Feb 23 04:20 PM
SAUNDERS BRENT LCEO and Chairman of the BoardMay 22 '25Buy11.2822,000248,072719,156May 27 08:16 AM
VON ESCHENBACH ANDREW C.DirectorMay 02 '25Buy11.761,69519,92541,748May 06 04:30 PM
Last Close
Apr 20  •  04:00PM ET
1.07
Dollar change
+0.01
Percentage change
0.94
%
LUCY Innovative Eyewear Inc daily Stock Chart
Index
-
P/E
-
EPS (ttm)
-2.10
Insider Own
12.03%
Shs Outstand
6.30M
Perf Week
-2.73%
Market Cap
6.74M
Forward P/E
-
EPS next Y
-0.45
Insider Trans
0.70%
Shs Float
5.54M
Perf Month
-4.46%
Enterprise Value
0.26M
PEG
-
EPS next Q
-0.47
Inst Own
6.22%
Perf Quarter
-24.11%
Income
-7.59M
P/S
2.53
EPS this Y
23.68%
Inst Trans
0.61%
Perf Half Y
-41.53%
Sales
2.66M
P/B
0.65
EPS next Y
68.97%
ROA
-75.99%
Perf YTD
7.38%
Book/sh
1.65
P/C
1.04
EPS next 5Y
-
ROE
-83.60%
52W High
4.97 -78.47%
Perf Year
-38.51%
Cash/sh
1.03
P/FCF
-
EPS past 3/5Y
50.36% 1.99%
ROIC
-83.47%
52W Low
0.95 12.63%
Perf 3Y
-98.27%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
59.19% 115.71%
Gross Margin
21.32%
Volatility
5.97% 5.86%
Perf 5Y
-
Dividend TTM
-
EV/Sales
0.10
EPS Y/Y TTM
68.99%
Oper. Margin
-319.16%
ATR (14)
0.06
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
6.94
Sales Y/Y TTM
62.65%
Profit Margin
-285.20%
RSI (14)
45.80
Dividend Gr. 3/5Y
- -
Current Ratio
9.03
EPS Q/Q
60.63%
SMA20
-1.54%
Beta
2.79
Payout
-
Debt/Eq
0.00
Sales Q/Q
38.96%
SMA50
-2.91%
Rel Volume
1.72
Prev Close
1.06
Employees
13
LT Debt/Eq
0.00
SMA200
-32.17%
Avg Volume
120.67K
Price
1.07
IPO
Aug 15, 2022
Option/Short
No / Yes
Trades
Volume
207,095
Change
0.94%
Apr-17-26 08:00AM
Apr-16-26 08:00AM
Apr-10-26 08:00AM
Mar-31-26 08:00AM
Mar-30-26 09:00PM
04:30PM Loading…
Mar-25-26 04:30PM
Mar-10-26 04:30PM
Feb-24-26 08:00AM
Feb-17-26 08:30AM
Jan-22-26 08:30AM
Jan-09-26 12:57PM
Jan-07-26 08:34PM
08:00AM
Dec-22-25 08:00AM
Dec-11-25 08:06AM
08:00AM Loading…
Nov-13-25 08:00AM
Nov-04-25 08:30AM
Oct-06-25 08:00AM
Sep-24-25 08:00AM
Sep-10-25 08:30AM
Aug-14-25 04:30PM
Aug-11-25 08:00AM
Jul-21-25 08:30AM
Jun-24-25 03:27PM
Jun-23-25 07:00AM
Jun-20-25 08:30AM
May-29-25 08:00AM
May-13-25 05:49PM
May-05-25 08:00AM
Apr-28-25 08:00AM
08:30AM Loading…
Apr-23-25 08:30AM
Apr-11-25 09:00AM
Apr-10-25 08:30AM
Apr-07-25 08:30AM
Mar-25-25 08:30AM
Feb-26-25 08:30AM
Feb-05-25 08:30AM
Jan-30-25 08:30AM
Jan-16-25 08:30AM
Jan-15-25 08:30AM
Dec-16-24 10:55PM
Nov-25-24 08:30AM
Nov-13-24 08:00AM
Nov-05-24 08:30AM
Oct-29-24 08:30AM
Oct-24-24 08:30AM
Oct-14-24 08:30AM
Oct-02-24 12:07PM
Sep-25-24 08:20PM
Sep-23-24 08:00AM
Sep-17-24 08:30AM
Sep-05-24 08:30AM
Sep-04-24 05:49PM
Sep-03-24 08:39AM
Aug-29-24 08:00AM
Aug-21-24 08:00AM
Aug-13-24 08:00AM
Aug-01-24 10:22AM
Jul-18-24 08:00AM
Jun-14-24 08:30AM
Jun-13-24 08:30AM
Jun-07-24 06:40AM
Jun-03-24 08:00AM
May-30-24 07:47AM
May-29-24 04:15PM
12:15PM
11:58AM
09:00AM
07:39AM
May-28-24 02:43PM
07:27AM
May-24-24 04:02PM
07:16AM
May-14-24 01:53PM
08:30AM
May-01-24 05:00PM
04:30PM
Apr-29-24 08:00AM
Apr-25-24 08:32AM
Apr-24-24 08:30AM
Apr-18-24 08:30AM
Apr-17-24 08:30AM
Mar-25-24 01:53PM
08:30AM
Feb-01-24 09:00AM
Jan-22-24 08:00AM
Jan-11-24 08:00AM
Jan-10-24 08:00AM
Jan-05-24 10:04AM
Dec-14-23 08:30AM
Dec-13-23 09:00AM
Dec-12-23 08:30AM
Dec-11-23 08:30AM
Nov-16-23 07:00AM
Oct-17-23 07:00AM
Oct-03-23 08:00AM
Sep-22-23 03:05PM
Sep-21-23 09:35AM
Sep-11-23 07:00AM
Aug-15-23 10:20AM
Innovative Eyewear, Inc. retails eye glasses online. It designs and provides smart glasses enhanced with tech features such as built-in Bluetooth audio connectivity, phone control buttons and instant AI voice assistant access. The company was founded by Harrison Gross, Konrad Dabrowski and David Eric Cohen in 2019 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gross Harrison R.OfficerApr 02 '26Proposed Sale1.0524,60025,830Apr 07 11:35 AM
Abondano JoaquinOfficerApr 02 '26Proposed Sale1.0514,80015,540Apr 02 04:50 PM
Cohen David EricOfficerApr 02 '26Proposed Sale1.0518,20019,110Apr 02 04:37 PM
Gayle OswaldOfficerApr 02 '26Proposed Sale1.0516,23317,045Apr 02 02:57 PM
Gross Harrison R.Chief Executive OfficerJan 21 '26Buy1.321,5001,98013,733Jan 22 11:29 AM
Gayle OswaldChief Financial OfficerJan 13 '26Buy1.671,0001,6692,865Jan 15 05:00 PM
Gross Harrison R.Chief Executive OfficerJan 08 '26Buy1.601,5002,40012,233Jan 12 05:00 PM
Dabrowski KonradChief AI & Growth OfficerJan 08 '26Buy1.581,3002,05412,804Jan 12 05:00 PM
Galkin Vladimir10% OwnerDec 04 '25Proposed Sale1.471,000,0001,470,000Dec 05 03:54 PM
Cohen David EricOfficerSep 24 '25Proposed Sale2.167591,641Sep 25 12:38 PM
Gayle OswaldOfficerSep 23 '25Proposed Sale2.253,7308,410Sep 24 11:46 AM
Cohen David EricOfficerSep 10 '25Proposed Sale2.127601,611Sep 10 02:40 PM
Dabrowski KonradOfficerAug 19 '25Proposed Sale1.952,5965,058Aug 19 01:22 PM
Abondano JoaquinOfficerAug 19 '25Proposed Sale1.951,4852,890Aug 19 01:17 PM
Gross Harrison R.OfficerAug 19 '25Proposed Sale1.963,0095,894Aug 19 01:12 PM
Cohen David EricOfficerAug 19 '25Proposed Sale1.992,2254,422Aug 19 11:02 AM
Gayle OswaldOfficerAug 19 '25Proposed Sale1.991,6703,317Aug 19 10:58 AM
Abondano JoaquinOfficerMay 14 '25Proposed Sale2.961,2643,735May 15 09:15 AM
Last Close
Apr 20  •  04:00PM ET
69.46
Dollar change
-0.60
Percentage change
-0.86
%
COO Cooper Companies Inc daily Stock Chart
Index
S&P 500
P/E
34.38
EPS (ttm)
2.02
Insider Own
0.67%
Shs Outstand
195.10M
Perf Week
-3.12%
Market Cap
13.55B
Forward P/E
13.80
EPS next Y
5.03
Insider Trans
1.24%
Shs Float
193.81M
Perf Month
-1.77%
Enterprise Value
15.93B
PEG
1.41
EPS next Q
1.10
Inst Own
104.49%
Perf Quarter
-15.67%
Income
401.40M
P/S
3.26
EPS this Y
12.05%
Inst Trans
-0.83%
Perf Half Y
-2.93%
Sales
4.15B
P/B
1.62
EPS next Y
9.03%
ROA
3.26%
Perf YTD
-15.25%
Book/sh
42.87
P/C
108.42
EPS next 5Y
9.81%
ROE
4.87%
52W High
89.83 -22.68%
Perf Year
-12.64%
Cash/sh
0.64
P/FCF
27.59
EPS past 3/5Y
-1.15% 9.30%
ROIC
3.92%
52W Low
61.78 12.44%
Perf 3Y
-27.89%
EV/EBITDA
14.54
Sales past 3/5Y
7.35% 10.98%
Gross Margin
60.69%
Volatility
2.17% 2.36%
Perf 5Y
-30.62%
EV/Sales
3.84
EPS Y/Y TTM
-2.65%
Oper. Margin
17.19%
ATR (14)
1.80
Perf 10Y
75.03%
Quick Ratio
0.79
Sales Y/Y TTM
5.69%
Profit Margin
9.67%
RSI (14)
38.14
Current Ratio
1.34
EPS Q/Q
28.28%
SMA20
-1.67%
Beta
0.99
Debt/Eq
0.30
Sales Q/Q
6.16%
SMA50
-8.19%
Rel Volume
0.75
Prev Close
70.06
Employees
15000
LT Debt/Eq
0.22
SMA200
-6.91%
Avg Volume
1.97M
Price
69.46
IPO
Jan 21, 1983
Option/Short
Yes / Yes
Trades
Volume
1,479,752
Change
-0.86%
Date Action Analyst Rating Change Price Target Change
Mar-04-26Downgrade Rothschild & Co Redburn Buy → Neutral $85
Feb-03-26Reiterated Needham Buy $100 → $99
Nov-13-25Downgrade Wells Fargo Overweight → Equal Weight $72
Oct-13-25Initiated Barclays Overweight $85
Oct-01-25Initiated Goldman Sell $64
Aug-28-25Downgrade Citigroup Buy → Neutral $72
Jul-22-25Upgrade BNP Paribas Exane Neutral → Outperform $92
Jun-17-25Upgrade Needham Hold → Buy $94
May-30-25Downgrade JP Morgan Overweight → Neutral $76
Aug-29-24Reiterated Piper Sandler Overweight $115 → $120
Apr-09-26 08:05AM
Mar-17-26 08:19AM
Mar-13-26 11:55AM
Mar-09-26 05:24PM
09:40AM
09:15AM Loading…
09:15AM
Mar-07-26 08:15AM
Mar-06-26 04:42PM
12:45PM
11:18AM
10:45AM
10:05AM
09:45AM
09:20AM
09:14AM
08:30AM Loading…
08:30AM
06:29AM
03:05AM
12:01AM
Mar-05-26 08:18PM
06:00PM
05:30PM
04:33PM
04:15PM
Mar-04-26 09:39AM
07:59AM
07:54AM
Mar-03-26 05:15PM
Mar-02-26 09:36AM
09:15AM
10:00AM Loading…
Feb-26-26 10:00AM
Feb-25-26 08:28AM
Feb-24-26 07:30PM
12:31PM
08:31AM
Feb-23-26 08:46AM
08:45AM
Feb-18-26 07:42AM
Feb-17-26 01:44PM
09:27AM
Feb-13-26 11:40AM
Feb-11-26 01:34PM
Feb-10-26 09:23AM
Feb-05-26 04:15PM
Feb-04-26 05:20PM
Feb-03-26 01:17PM
12:10PM
08:05AM
Feb-02-26 11:57AM
Jan-29-26 11:38PM
12:17PM
Jan-28-26 11:40AM
Jan-27-26 12:19PM
09:45AM
Jan-26-26 09:40AM
Jan-23-26 01:50PM
07:57AM
Jan-22-26 11:08AM
10:43AM
Jan-21-26 11:43AM
Jan-14-26 12:50PM
Jan-13-26 11:16AM
Jan-12-26 11:40AM
Jan-07-26 03:00PM
Jan-06-26 08:00AM
Jan-05-26 07:17AM
Jan-01-26 10:32PM
Dec-31-25 07:36AM
Dec-30-25 02:04PM
07:33AM
Dec-29-25 04:15PM
Dec-26-25 11:40AM
Dec-23-25 08:00AM
Dec-22-25 12:12PM
Dec-19-25 09:55AM
Dec-16-25 11:05PM
11:37AM
Dec-12-25 09:50AM
Dec-11-25 07:34AM
12:31AM
Dec-10-25 11:40AM
Dec-08-25 09:40AM
09:15AM
Dec-05-25 11:11AM
11:02AM
09:11AM
07:36AM
02:46AM
12:31AM
12:02AM
Dec-04-25 06:30PM
05:25PM
04:45PM
04:20PM
04:15PM
Dec-03-25 05:15PM
12:45PM
Dec-02-25 10:04PM
Dec-01-25 09:15AM
06:11AM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEISS ROBERT SDirectorApr 01 '26Option Exercise0.003,6540292,599Apr 06 05:16 PM
Rivas MariaDirectorApr 01 '26Option Exercise0.003,32203,322Apr 06 05:16 PM
Jay ColleenDirectorApr 01 '26Option Exercise0.003,322039,907Apr 06 05:16 PM
Carbone BarbaraDirectorApr 01 '26Option Exercise0.003,05003,050Apr 06 05:15 PM
MADDEN TERESA SDirectorApr 01 '26Option Exercise0.003,322015,679Apr 06 05:15 PM
Lucchese Cynthia LDirectorApr 01 '26Option Exercise0.003,322012,767Apr 06 05:14 PM
Kurzius Lawrence ErikDirectorApr 01 '26Option Exercise0.003,322011,099Apr 06 05:14 PM
Jay ColleenDirectorJan 12 '26Option Exercise39.407,064278,32236,585Jan 14 04:05 PM
White Albert G IIIPresident & CEOJan 08 '26Option Exercise0.0018,3400254,491Jan 12 04:24 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08 '26Option Exercise0.0011,518029,837Jan 12 04:24 PM
Sheffield Holly RPresident, CSIJan 08 '26Option Exercise0.008,050047,102Jan 12 04:23 PM
McBride Daniel GEVP & Chief Operating OfficerJan 08 '26Option Exercise0.0012,887076,007Jan 12 04:23 PM
Andrews Brian GEVP, CFO & TreasurerJan 08 '26Option Exercise0.003,528010,430Jan 12 04:22 PM
Lucchese Cynthia LDirectorDec 22 '25Buy84.061,784149,9639,445Dec 23 04:08 PM
Rivas MariaDirectorDec 18 '25Buy82.131,00082,13011,141Dec 19 04:18 PM
Kurzius Lawrence ErikDirectorDec 17 '25Buy82.502,000165,0007,777Dec 17 05:06 PM
Sheffield Holly RPresident, CSIDec 16 '25Buy80.751,23099,32239,052Dec 16 06:36 PM
White Albert G IIIPresident & CEODec 16 '25Buy80.8010,000808,000236,151Dec 16 06:36 PM
Kurzius Lawrence ErikDirectorSep 29 '25Buy68.392,000136,7805,777Sep 29 08:36 PM
White Albert G IIIPresident & CEOSep 05 '25Buy68.3910,000683,900226,151Sep 05 05:10 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Sep 05 '25Buy69.231,450100,38418,319Sep 05 04:07 PM
McBride Daniel GEVP & Chief Operating OfficerSep 02 '25Buy65.043,000195,12063,120Sep 02 05:17 PM
Andrews Brian GEVP, CFO & TreasurerSep 02 '25Buy65.681,525100,16222,191Sep 02 05:16 PM